🧬 Genetic Disorder

Ectodermal Dysplasia

Also known as: ED, Hypohidrotic Ectodermal Dysplasia (HED), Anhidrotic Ectodermal Dysplasia, Christ-Siemens-Touraine Syndrome

Ectodermal dysplasias (EDs) are a group of genetic disorders characterized by abnormal development of ectodermal structures, including the skin, hair, teeth, and sweat glands. The severity and specific features vary widely depending on the specific gene affected. Some individuals may have mild symptoms, while others experience significant functional and cosmetic challenges. The most common form is hypohidrotic ectodermal dysplasia (HED), characterized by reduced or absent sweating, sparse hair, and abnormal or missing teeth.

👥 1 in 10,000 births Prevalence
🔬 15 Active Trials

Imagine your body has trouble making things like sweat, hair, and teeth. Ectodermal dysplasia is when some parts of your body that are supposed to make these things don't work right. So, you might not sweat enough, have thin hair, or have missing teeth. Doctors can help with special ways to stay cool and get new teeth.

Signs & Symptoms

  • Sparse hair (hypotrichosis)
  • Reduced or absent sweating (hypohidrosis or anhidrosis)
  • Abnormal or missing teeth (hypodontia or anodontia)
  • Dry skin
  • Thickened nails
  • Craniofacial abnormalities (e.g., prominent forehead, saddle nose)
  • Heat intolerance
  • Eczema
  • Respiratory infections
  • Dry eyes

Treatment Options

SUPPORTIVE

Cooling measures (e.g., fans, cooling vests)

MODERATELY EFFECTIVE
SUPPORTIVE

Artificial tears

MODERATELY EFFECTIVE
SUPPORTIVE

Emollients and moisturizers

MODERATELY EFFECTIVE
SUPPORTIVE

Dental prosthetics (e.g., dentures, implants)

HIGHLY EFFECTIVE
GENE THERAPY

Gene therapy (experimental)

EXPERIMENTAL
THERAPY

Ectodysplasin A replacement therapy

EXPERIMENTAL
MEDICATION FDA Approved

Antibiotics (for infections)

HIGHLY EFFECTIVE

Diagnosis

  • Clinical examination
  • Family history
  • Genetic testing (e.g., sequencing of EDA, EDAR, EDARADD, WNT10A genes)
  • Skin biopsy (to assess sweat gland function)
  • Dental X-rays
  • Physical Examination

History

Ectodermal dysplasia was first described in the late 19th century. The term 'anhidrotic ectodermal dysplasia' was coined by Thurmon in 1921. The X-linked inheritance pattern of the most common form (HED) was established in the mid-20th century. The identification of the EDA gene and its role in ectodermal development in the 1990s marked a significant breakthrough in understanding the molecular basis of ED.

Recent Breakthroughs

2020

Long-term safety and efficacy of ER-004 (recombinant ectodysplasin A) in X-linked hypohidrotic ectodermal dysplasia

A clinical trial demonstrated the long-term safety and efficacy of ER-004, a recombinant ectodysplasin A replacement therapy, in improving sweat gland function and quality of life in individuals with X-linked hypohidrotic ectodermal dysplasia.

2022

Prenatal treatment with recombinant ectodysplasin A1 prevents manifestations of X-linked hypohidrotic ectodermal dysplasia

A study showed that prenatal administration of recombinant ectodysplasin A1 could prevent the development of X-linked hypohidrotic ectodermal dysplasia in affected fetuses, offering a potential avenue for early intervention.